Skip to main content
CM

Cebreo Medical

Cebreo Medical provides in-ear EEG earbuds and an AI-powered analytics platform for continuous, medical-grade brain activity monitoring in natural settings. Their solution enables precision neuroscience research and decentralized clinical trials by facilitating unassisted data acquisition for digital biomarker development in neurological conditions.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional EEG monitoring is often confined to clinical settings, limiting the ability to capture natural brain activity and longitudinal data. This constraint hinders the development of digital biomarkers and the comprehensive understanding of neurological conditions in real-world environments.

Solution

Cebreo Medical offers NeuroBuds, comfortable in-ear earbuds designed for continuous, medical-grade EEG and activity monitoring in natural settings. Their AI-powered platform provides advanced analytics for precision neuroscience research and decentralized clinical trials. This end-to-end solution facilitates unassisted data acquisition, enabling the development of digital biomarkers for conditions such as sleep disorders, epilepsy, and neurodegenerative diseases. The platform supports remote monitoring, data quality oversight, and scientific consultation throughout the research lifecycle.

Target Audience

The primary customers are clinical researchers and healthcare professionals focused on neuroscience, particularly those conducting clinical trials for neurological conditions and developing digital biomarkers.

Features

  • In-ear EEG earbuds for comfortable, around-the-clock ambulatory monitoring.
  • AI-powered analytics platform for processing electrophysiology and activity data.
  • End-to-end solution for decentralized clinical trials, supporting unassisted data acquisition.
  • Digital biomarker development for neurological conditions, including sleep, epilepsy, and neurodegenerative diseases.
  • Secure study and user management portal for real-time data monitoring and participant adherence tracking.
  • Scientific and operational support, including study design input, certified EEG annotations, and advanced data analytics.
  • HIPAA-compliant data storage with end-to-end encryption.
This profile is AI-generated and may contain inaccuracies.